Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Vicotex

Download Mobile App




Beckman to Buy DSL, Expand Endocrine Testing

By HospiMedica staff writers
Posted on 17 Oct 2005
In a move to gain leadership in specialty endocrine testing, Beckman Coulter, Inc. More...
(Fullerton, CA, USA) has agreed to acquire Diagnostic Systems Laboratories Corp. (DSL, Webster, TX, USA). Financial details were not disclosed.

DSL is a leading provider of specialty immunoassays, including proprietary technology for reproductive endocrinology and cardiovascular risk assessment. With 2004 sales of around U.S.$34 million, DSL competes in the specialty endocrinology segment of the immunoassay market. The company markets three proprietary reproductive endocrinology tests, including Inhibin A and B, and anti-Mullerian hormone. In addition, DSL holds exclusive rights to PAPP-A, a marker being evaluated for cardiovascular risk assessment. Currently, endocrinology makes up about 10% of the $5 billion immunoassay market. DSL has satellite laboratories in Germany, the United Kingdom, and Canada.

"DSL is a mature organization with significant scientific and clinical collaboration skills,” said Michael Whelan, group vice president of Beckman Coulter's immunoassay business. "Together we aim to quickly broaden our immunoassay menu and strategically advance our already successful immunoassay franchise.”

DSL has a proven history of collaboration with clinical research leaders to identify new and innovative immunoassays to improve patient care. The company has successfully combined these relationships with a rapid product development process to quickly deliver novel tests to the pharmaceutical and life science research community as well as the traditional clinical laboratory.





Related Links:
Beckman Coulter
DSL

Platinum Member
Automated Coagulation Analyzer
Hemolumi H6
Gold Member
Automatic Hematology Analyzer
CF9600
Automated Urinalysis Solution
UN-9000
Electrolyte Analyzer
BKE-B
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image Credit: Adobe Stock

Blood Biomarkers Help Assess Growth Risks During Steroid Treatment in Duchenne Muscular Dystrophy

Children with Duchenne muscular dystrophy (DMD) commonly receive long-term corticosteroids to slow disease progression, but these drugs can impair linear growth and weaken bone. Understanding how specific... Read more

Molecular Diagnostics

view channel
Image: The Xpert Hemorrhagic Fever Panel test runs on Cepheid’s GeneXpert Dx systems (Photo courtesy of Cepheid)

WHO Emergency Listing Supports Rapid Molecular Testing for Ebola Outbreak Response

The Democratic Republic of the Congo is confronting an Ebola Bundibugyo outbreak that the World Health Organization (WHO) designated a Public Health Emergency of International Concern on May 17, 2026.... Read more

Microbiology

view channel
Image Credit: Adobe Stock

Gut Microbiome Classifier Improves Colorectal Cancer Risk Stratification

Colorectal cancer remains a leading cause of cancer mortality, and current noninvasive screening methods still miss many precancerous lesions. Clinicians therefore need tools that improve risk stratification... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.